NECSTGEN

NECSTGEN is located in Leiden, Netherlands on Sylviusweg 62. NECSTGEN is rated 3 out of 5 in the category pharmaceuticals in Netherlands. The Netherlands Center for the Clinical advancement of Stem Cell and Gene Therapies (NECSTGEN), situated in Leiden, will comprise a state of the art facility and expert knowledge for the development, production, and commercialization of cell and gene therapies. NECSTGEN is not a regular CDMO but a non-profit initiative aimed at delivering more therapies to patients by the translation of research and early-stage clinical programs into viable commercial products. NECSTGEN helps early stage research organizations and start-ups to enter the clinical stage by bringing together the required expertise from R&D, development, production, QA and regulatory affairs in a non-profit GMP production facility. Moreover, NECSTGEN will focus on orphan diseases that may be underserved but are nevertheless catastrophic to people who suffer from them. NECSTGEN is not a regular CDMO but a non-profit initiative aimed at delivering more therapies to patients by the translation of research and early-stage clinical programs into viable commercial products. NECSTGEN helps early stage research organizations and start-ups to enter the clinical stage by bringing together the required expertise from R&D, development, production, QA and regulatory affairs in a non-profit GMP production facility. Development activities and collaboration are critical given the bottlenecks faced by the industry today and the resulting high therapy costs that society pays for. NECSTGEN will offer: *A flexible cell and gene therapy production model *Full GMP production by our expert team *Support of your own team by ours for GMP production *GMP laboratory rental *Quality Control *Quality Assurance *Process and assay development *Process optimization *Scale-up of existing processes *Assay Development *Technology transfer *Regulatory support or consultancy for Chemistry Manufacturing Controls *Business development